Cytosorbents (CTSO) Inventory (2011 - 2026)

Cytosorbents' Inventory history runs 16 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• Quarterly Inventory rose 48.45% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (up 48.45% YoY) and the FY2025 annual result came in at $5.3 million, up 93.67% from the prior year.
• Inventory was $4.5 million for Q1 2026 at Cytosorbents, down from $5.3 million in the prior quarter.
• Across five years, Inventory topped out at $5.4 million in Q1 2022 and bottomed at $1.7 million in Q1 2023.
• A 5-year average of $3.7 million and a median of $3.5 million in 2022 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory sank 68.31% — and 2024, when it soared 116.66%.
• Cytosorbents' Inventory stood at $3.5 million in 2022, then decreased by 2.48% to $3.4 million in 2023, then fell by 19.04% to $2.7 million in 2024, then soared by 93.67% to $5.3 million in 2025, then decreased by 15.34% to $4.5 million in 2026.
• Business Quant data shows CTSO's Inventory at $4.5 million in Q1 2026, $5.3 million in Q4 2025, and $4.0 million in Q3 2025.